Stay updated on DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial
Sign up to get notified when there's something new on the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page.

Latest updates to the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedAdds a related disease topic, Hereditary factor IX deficiency, and links to Genetic and Rare Diseases Information Center resources on the study page.SummaryDifference0.2%

- Check17 days agoChange DetectedHemophilia B is removed from the page content. The Genetic and Rare Diseases Information Center resource link in Resources is removed.SummaryDifference0.2%

- Check24 days agoChange DetectedThe page shows a revision label update from v3.4.3 to v3.5.0. It does not modify study details or related content.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page now shows Revision: v3.4.3; the previous Revision: v3.4.2 has been removed.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding status notice (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedA site-wide notice about potential disruptions due to a lapse in government funding has been added, with links to cc.nih.gov and opm.gov for updates. The page version was updated from 3.4.0 to 3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page.